ALNY
Alnylam Pharmaceuticals Inc
249.60$
+1.2%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | 0.19 | 0.36 | 0.26 | 0.84 | 1.32 | 2.34 | 2.41 | 2.38 | 1.95 | 1.33 | 0.77 | 0.68 | 0.49 | 0.55 | 0.99 | 0.74 | 2.01 | 4.29 | 7.13 | 8.53 | 14.64 | 17.61 | 27.58 | |
| – | 20.99 | 2.87 | 2.10 | 1.96 | 3.52 | 2.88 | 3.43 | 3.26 | 3.12 | 2.44 | 2.18 | 3.09 | 3.93 | 5.40 | 6.38 | 0.02 | 0.23 | 0.68 | 1.18 | 1.39 | 2.49 | 2.53 | 5.03 | |
| – | 0.19 | 0.36 | 0.26 | 0.84 | 1.32 | 2.34 | 2.41 | 2.38 | 1.95 | 1.33 | 0.77 | 0.68 | 0.49 | 0.55 | 0.99 | 0.73 | 1.78 | 3.61 | 5.94 | 7.14 | 12.15 | 15.08 | 22.55 | |
| 10.09 | 13.89 | 2.07 | 1.61 | 1.56 | 3.12 | 2.36 | 2.61 | 2.53 | 2.34 | 1.72 | 1.84 | 2.56 | 3.29 | 4.47 | 4.31 | 5.02 | 6.00 | 5.69 | 6.69 | 7.26 | 8.04 | 8.82 | 9.83 | |
| – | 7.98 | 1.00 | 0.63 | 0.52 | 0.61 | 0.66 | 0.96 | 0.90 | 0.90 | 0.89 | 0.44 | 0.60 | 0.72 | 1.04 | 2.20 | 3.80 | 4.38 | 5.12 | 5.24 | 6.33 | 6.37 | 7.64 | 8.99 | |
| 12.74 | 21.88 | 3.07 | 2.24 | 2.08 | 3.73 | 3.02 | 3.57 | 3.43 | 3.24 | 2.61 | 2.28 | 3.16 | 4.01 | 5.51 | 6.52 | 8.83 | 10.38 | 10.81 | 11.93 | 13.59 | 14.41 | 16.46 | 18.82 | |
| -12.74 | -26.58 | -2.71 | -1.98 | -1.24 | -2.41 | -0.68 | -1.16 | -1.05 | -1.29 | -2.57 | -1.51 | -5.45 | -3.52 | -4.96 | -5.52 | -8.10 | -8.60 | -7.20 | -5.98 | -6.45 | -2.26 | -1.39 | 3.72 | |
| 0.00 | 0.00 | 0.06 | 0.04 | 0.03 | 0.03 | 0.02 | 0.13 | 0.05 | 0.03 | 0.02 | 0.02 | 0.03 | 0.07 | 0.10 | 0.14 | 0.29 | 0.99 | 0.73 | 1.21 | 1.28 | 0.97 | 1.11 | 1.88 | |
| – | -31.50 | -2.98 | -1.96 | -1.09 | -2.08 | -0.62 | -1.13 | -1.02 | -1.36 | -2.32 | -1.49 | -5.39 | -3.45 | -4.79 | -5.42 | -7.56 | -8.10 | -7.44 | -7.19 | -9.26 | -3.47 | -2.96 | 2.40 | |
| -0.26 | -4.86 | 0.03 | -0.03 | -0.15 | 0.14 | 0.02 | 0.01 | 0.01 | -0.14 | -0.21 | -0.04 | -0.54 | -0.30 | -0.27 | -0.28 | 0.01 | 0.01 | 0.02 | 0.01 | 0.03 | 0.05 | -0.78 | 0.07 | |
| -12.48 | -26.56 | -2.75 | -1.96 | -1.09 | -2.21 | -0.64 | -1.14 | -1.04 | -1.36 | -2.11 | -1.45 | -4.85 | -3.45 | -4.79 | -5.42 | -7.57 | -8.11 | -7.46 | -7.20 | -9.30 | -3.52 | -2.18 | 2.33 | |
| -12.63 | -20.80 | -2.49 | -1.77 | -1.12 | -1.94 | -0.46 | -0.99 | -0.91 | -1.17 | -1.03 | -1.34 | -2.32 | -3.30 | -4.78 | -5.37 | -7.50 | -8.10 | -6.40 | -5.59 | -7.61 | -2.07 | -1.40 | 4.69 |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.